Robert A Shalwitz

This inventor holds 33 USPTO granted patents and 37 published patent applications, plus 9 CIPO patents and 18 EPO patents, primarily in Cancer Treatment. Top assignees: Aerpio Therapeutics, Inc., Invirsa, Inc., Abbott Laboratories Corporation. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert A Shalwitz. Retrieved from https://idiyas.com/inventor/robert-a-shalwitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 37)

% Patents Active = 72.7

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 18 (Patent Applications = 23)

Average Co-Inventor Count = 2.0

ph-index = 12

Forward Citations = 380(Granted Patents)

Location History:

Columbus, OH (US) (2001)
Bexley, OH (US) (2012 - 2024)

Company Filing History:

19 out of 35

Aerpio Therapeutics, Inc.

Abbott Laboratories Corporation

patents

4. 2 out of 38

Akebia Therapeutics, Inc.

patents

5. 2 out of 23

Eyepoint Pharmaceuticals, Inc.

patents

6. 1 out of 8

Aerpio Pharmaceuticals, Inc.

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

Prolyl Hydroxylase Inhibitors

Ocular Diseases

Vascular Leak Syndrome

Hypoxia Inducible Factor

Cancer Metastasis

Anemia Treatment

Breast Health

Colitis Treatment

ADPR

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370209 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2025-07-29),

2. 12233083 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2025-02-25),

3. 12152023 - Compositions, formulations and methods for treating ocular diseases (2024-11-26),

4. 12043664 - Methods for treating vascular leak syndrome and cancer (2024-07-23),

5. 11857561 - Methods for the use of 5′-adenosine diphosphate ribose (ADPR) (2024-01-02),

6. 11857543 - Compositions and methods for treating anemia (2024-01-02),

7. 11793826 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2023-10-24),

8. 11110112 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2021-09-07),

9. 10946034 - Methods for the use of 5'-adenosine diphosphate ribose (ADPR) (2021-03-16),

10. 10815300 - Methods for treating vascular leak syndrome and cancer (2020-10-27),

11. 10562854 - Prolyl hydroxylase inhibitors (2020-02-18),

12. 10329357 - Treatment of ocular disease (2019-06-25),

13. 10220048 - Compositions and methods for treating ocular diseases (2019-03-05),

14. 10150811 - Methods for treating vascular leak syndrome and cancer (2018-12-11),

15. 9949956 - Compounds, compositions, and methods for preventing metastasis of cancer cells (2018-04-24),

Title: The Inventor Profile of Robert A. Shalwitz

Introduction: Robert A. Shalwitz is a distinguished inventor based in Columbus, Ohio, known for his groundbreaking contributions to various fields.

Latest Patents: Robert A. Shalwitz holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: With a career spanning over two decades, Robert A. Shalwitz has been at the forefront of innovation, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Robert A. Shalwitz has collaborated with leading companies, research institutions, and universities to bring his ideas to life and make a lasting impact on society.

Conclusion: Robert A. Shalwitz's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the industry.

Profile summary based on public USPTO records.